Item 5.07. Submission of Matters to a Vote of Security Holders.

Uroplasty, Inc. held its annual meeting of shareholders on September 13, 2012. At the meeting, each of Lee A. Jones and David B. Kaysen were reelected as class I directors to serve until the annual shareholder meeting in 2015 or until their successors are elected and qualify. The shareholders also ratified the appointment of Grant Thornton LLP as Uroplasty's independent registered public accounting firm for the year ending March 31, 2013.

As of the July 16, 2012 record date for the meeting, there were 20,926,582 shares of common stock issued and outstanding and 19,069,553 shares were represented at the annual meeting. The voting results were as follows:

1. Election of Directors

For Withheld Broker Non-Votes Lee A. Jones 12,147,018 221,257 6,701,278 David B. Kaysen 12,149,303 218,972 6,701,278

2. Ratification of Auditors

Shareholders ratified the appointment of Grant Thornton LLP by a vote of 19,017,828 shares in favor, 22,853 shares against, 28,872 shares abstaining, and no broker non-votes.